nsolver-background-blog

Top 5 reasons why nSolver 4.0 and Advanced Analysis 2.0 will change your (data analysis) life

Your data doesn’t fit in a box. Gone are the days of assay-specific data analysis. nSolver 4.0 is analyte focused and less assay restricted. This means that any combination of analytes you can dream up is supported. Customize your experiment...

/ November 22, 2017
3Dbiology_Banner

Q&A with Dr. David Coffey, FHCRC: Multi-analyte studies in multiple myeloma and lymphoma

David Coffey, MD, is a physician scientist with the Fred Hutchinson Cancer Research Center in Seattle, Washington. When he’s not treating patients, he’s in the lab researching blood cancers such as multiple myeloma and lymphoma. His research centers on the...

/ November 16, 2017
3Dbiology_Banner

Moving Toward the Clinic- Leveraging Xenograft Models for Preclinical Anti-Cancer Studies

The use of cancer cell lines for in vitro studies of anti-cancer agents remains a primary component of preclinical drug development. These studies, however, struggle with significant pitfalls given the unique biology of cancer cell lines and the artificial assay...

/ November 2, 2017
nsolver-background-blog

Welcome to the nSolver™ Software Tech Blog!

We love that you’re here. Here’s why you’re going to love it, too: Fun-size articles on nSolver & Advanced Analysis. In between scientific papers, grant applications, and your other lengthy reading obligations, our blog post will be a fresh change...

/ October 25, 2017
3D-Bio_prison-01_blog

Taking off the Blinders- The Acceleration of Integrated Multi-omic Analysis

Typically our fields require us to specialize; geneticists profile DNA and RNA, flow cytometrists look at extracellular protein markers, and system biologists look at complex data from six different instruments. We often stay in our single-omic lane, only deviating when absolute necessity...

/ October 18, 2017